Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores-Reference-Cited by-同舟云学术

Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores

Published:2015-04-24 Issue:3 Volume:83 Page:420-428
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Diakatou Evanthia¹,Alexandraki Krystallenia I.²,Tsolakis Apostolos V.³,Kontogeorgos George¹,Chatzellis Eleftherios²,Leonti Anastasia⁴,Kaltsas Gregory A.²

Affiliation:

1. Department of Pathology; “G. Gennimatas” Athens General Hospital; Athens Greece

2. Department of Pathophysiology; University of Athens; Athens Greece

3. Department of Medical Sciences; Section of Endocrine Oncology; Uppsala University; Uppsala Sweden

4. Department of Nuclear Medicine; Alexandra Hospital; Athens Greece

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference34 articles.

1. Somatostatin and its receptor family;Patel;Frontiers in Neuroendocrinology,1999

2. The role of somatostatin and its analogs in the diagnosis and treatment of tumours;Lamberts;Endocrine Reviews,1991

3. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumours;Hofland;Journal of Clinical Endocrinology and Metabolism,1999

4. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumours using in situ hybridization;Reubi;Cancer Research,1994

5. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide lar in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the promid study group;Rinke;Journal of Clinical Oncology,2009

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms;Therapeutic Advances in Medical Oncology;2024-01

2. Dynamic 68Ga-DOTA0-Tyr3-octreotate positron emission tomography-computed tomography for the evaluation of pancreatic neuroendocrine tumors: a pilot study;Quantitative Imaging in Medicine and Surgery;2023-09

3. A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients;EJNMMI Research;2023-02-03

4. Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough;EJNMMI Research;2022-12-14

5. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors;Frontiers in Oncology;2022-11-17